Stay updated on Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Publications are described as auto-filled from PubMed, and the page revision was updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T14:53:02.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page no longer displays a site-wide government funding/operating status notice, which does not affect the trial data or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T07:35:51.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Results for the RELIVE study have been posted on the page, and the Study Record Dates now show a Results First Posted date of 2021-06-02.
    Difference
    0.2%
    Check dated 2025-10-27T21:11:36.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Major update: new operating-status notice and a v3.2.0 release; removal of the old v3.1.0 tag.
    Difference
    2%
    Check dated 2025-10-06T08:44:18.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T07:32:14.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Updated the location from Bourgoin-Jallieu, France, 38302 to Bourgoin, France, 38302 and bumped the revision from v3.0.1 to v3.0.2; removed the 'Back to Top' link. This is a minor editorial change with no impact on pricing, stock, or time-slot availability.
    Difference
    0.2%
    Check dated 2025-09-14T23:21:11.000Z thumbnail image

Stay in the know with updates to Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.